Ocular Therapeutix is a company focused on the development and commercialization of ophthalmic therapies.

Ocular Therapeutix

Kala Pharmaceuticals is a pharmaceutical company specializing in ophthalmic therapies.

Kala Pharmaceuticals

DaVita is a healthcare company primarily focused on kidney care services.

DaVita

UT Health is a healthcare institution providing medical education, research, and patient care.

UT Health

Strive Health is a company specializing in kidney care and value-based kidney disease management.

Strive Health

MSD is a global pharmaceutical company engaged in the discovery, development, and commercialization of healthcare products.

Ocumension Therapeutics is a biopharmaceutical company focused on the development and commercialization of innovative ophthalmic therapies. The company aims to address critical unmet medical needs in eye diseases through a robust pipeline of products.

Ocumension Therapeutics, together with its subsidiaries, operates as an ophthalmic pharmaceutical platform company in the People's Republic of China. The company discovers, develops, and commercializes therapies for ophthalmic patients. It offers drugs for the treatment of blepharitis, infective and allergic conjunctivitis, dry eye, cataract, glaucoma and ocular hypertension, postoperative inflammation, uveitis, retinitis pigmentosa, age-related macular degeneration, cornea graft rejection, myopia, and optic neuritis. As of December 31, 2021, the company had 20 drug assets in its portfolio. Ocumension Therapeutics was founded in 2017 and is headquartered in Suzhou, the People's Republic of China.

Ocumension Therapeutics

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jun 22, 2024 9:17 AM	ef86c773
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jun 22, 2024 11:16 AM	f02bd69e
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	7a08c257
crunchbase profile	general
li profile	general
translate crunchbase fundingrounds	general
peers	general
news basic	general	Jun 22, 2024 9:17 AM	da060ce8
bundesanzeiger	filings
financials download nd	financials
private financials	financials

1477

COM:OCUMENSION

Ocumension Therapeutics

Last Close

5.19

25/11 08:08

Market Cap

4.65B

Beta: -

Volume Today

1.48M

Avg: -